Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0001209191-23-039134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-22 | 2023-06-20 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +22.4K | 169.0K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-20 | A | A | 22,350 | $0.00 | 168,980 | D | — | — | (F2) Since the date of the reporting person's last ownership report, the individual transferred 5,009 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse. |